Incidence of Glucose Dysregulation in Patients with COVID-19 in Babylon Governorate, Iraq

Yasameen Alsaffar; Ashraf MA  Hussain; Ali Jaber Aboob Al-Mamoori

Yasameen Alsaffar Lecturer, Adv. Doc. (Endocrinology) Macquarie University Sydney Australia, F.I.B.M.S (Internal Medicine) University of Babylon, Iraq.
Ashraf MA Hussain Llecturer, PhD, Department of Family and Community Medicine, College of Medicine, University of Babylon, Iraq.
Ali Jaber Aboob Al-Mamoori Assistant Professor, College of Medicine, University of Babylon, Iraq.

Keywords: Incidence, Glucose Dysregulation, COVID-19

Abstract

Introduction: COVID-19 is a novel illness caused by an RNA Coronavirus. Diabetes was a risk factor for poor outcomes in the previous SARS-1 and Middle East Respiratory Syndrome (MERS) and is considered now an independent risk factor for poor outcomes in cases of SARS-2 (COVID-19). A number of studies referred to the association between COVID infection and impaired glycaemic state.

Aims: To find the incidence of dysglycaemia in COVID-19 patientsand assess characteristics that put the patients at higher riskof it.

Method: A total of 148 patientsadmitted between JuneandSeptember 2020 with a diagnosis of COVID-19 were included, anddivided into 3 glycaemic groups.

Results: In 148 patients diagnosed with COVID 19, dysglycaemiawas disclosed in 55.4% with frank new-onset diabetes in more than half of them (56%).Younger aged patients, those with higherweight, and longer disease duration were at higher risk.Further, the mean lung involvement presented by CT scan was higher in those with dysglycaemia.

Conclusion: More than 50% of COVID patients developed dysglycaemia for the first time. Young age, high weight, and long disease duration were significant risk factors.

How to cite this article:
Alsaffar Y, Hussain AMA, Al-Mamoori AJA. Incidence of Glucose Dysregulation in Patients with COVID-19 in Babylon Governorate, Iraq. Special Issue - COVID-19 & Other Communicable Disease. 2022;181-185.

DOI: https://doi.org/10.24321/0019.5138.202229

References

Abdi A, Jalilian M, Sarbarzeh P, Vlaisavljevic Z. Diabetes and COVID-19: asystematic review on the current evidences. Diabetes Res ClinPract. 2020 Aug;166:108347. [PubMed] [Google Scholar]

Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, Mingrone G, Boehm B, Cooper ME, Chai Z, Del Prato S, Ji L, Hopkins D, Herman WH, Khunti K, Mbanya JC, Renard E. New-onset diabetes in Covid-19. N Engl J Med. 2020 Aug;383(8):789-90. [PubMed] [Google Scholar]

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes MetabSyndr. 2020 Jul-Aug;14(4):303-10. [PubMed] [Google Scholar]

Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: are there possible cause and effect relationships among them? Diabetes ObesMetab. 2020 Dec;22(12):2507-8. [PubMed] [Google Scholar]

Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020 Mar;e33213321. [PubMed] [Google Scholar]

Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID-19: causality or coincidence? A report of three cases. J Med Virol. 2021 Feb;93(2):1150-3. [PubMed] [Google Scholar]

Reddy PK, Kuchay MS, Mehta Y, Mishra SK. Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature. Diabetes MetabSyndr. 2020 Sep-Oct;14(5):1459-62. [PubMed] [Google Scholar]

Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res ClinPract. 2020 Sep;167:108382. [PubMed] [Google Scholar]

Annis AM, Caulder MS, Cook ML, Duquette D. Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002. Prev Chronic Dis. 2005 Apr;2(2):A19. [PubMed]

Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res ClinPract. 2020 Jun;164:108166. [PubMed] [Google Scholar]

Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes ObesMetab. 2020 Oct;22(10):1935-41. [PubMed] [Google Scholar]

Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. ActaDiabetol. 2010 Sep;47(3):193-9. [PubMed] [Google Scholar]

Azar W, Njeim R, Fares A, Azar N, Azar S, Sayed M, Eid A. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev EndocrMetabDisord. 2020 Dec;21(4):451-63. [PubMed] [Google Scholar]

Kloc M, Ghobrial RM, Lewicki S, Kubiak JZ. Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM? J Diabetes MetabDisord. 2020;19:2045-8. [Google Scholar]

Muniyappa R, Wilkins KJ. Diabetes, obesity, and risk prediction of severe COVID-19. J ClinEndocrinolMetab. 2020 Oct;105(10):dgaa442.[PubMed] [Google Scholar]

Vas P, Hopkins D, Feher M, Rubino F, Martin BW. Diabetes, obesity and COVID-19: acomplex interplay.Diabetes ObesMetab. 2020 Oct;22(10):1892-6.[PubMed] [Google Scholar]

Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2021 Mar;47(2):101204. [PubMed] [Google Scholar]

Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: are there possible cause and effect relationships among them?Diabetes ObesMetab. 2020 Dec;22(12):2507-8. [PubMed] [Google Scholar]

Balasubramanyam M. Does COVID-19 warn us to revisit virus-induced diabetes? Explor Res Hypothesis Med. 2020;5(4):129-33. [Google Scholar]